CenterBook Partners’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17M | Buy |
3,430,255
+2,007,743
| +141% | +$4.2M | 0.4% | 56 |
|
|
2025
Q1 | $2.43M | Buy |
1,422,512
+142,673
| +11% | +$243K | 0.15% | 170 |
|
|
2024
Q4 | $6.46M | Buy |
+1,279,839
| New | +$6.46M | 0.39% | 77 |
|
|
2022
Q3 | – | Sell |
-41,470
| Closed | -$133K | – | 416 |
|
|
2022
Q2 | $133K | Sell |
41,470
-4,282
| -9% | -$13.7K | 0.03% | 370 |
|
|
2022
Q1 | $323K | Buy |
45,752
+22,046
| +93% | +$156K | 0.12% | 277 |
|
|
2021
Q4 | $172K | Buy |
+23,706
| New | +$172K | 0.1% | 272 |
|